soul study semaglutide Evaluating the Cardiovascular Benefits of Innovator 2.4 mg (Recombinant DNA (r-DNA)) in Patients With Overweight or Obesity: A Critical Review of Current Evidence SOUL: Oral Semaglutide Cuts CV

Related Reading Ozempic For Weight Loss 2 Average Weight Loss On Ozempic Mounjaro For Weight Loss 2 Weight Loss Drugs Like Ozempic Pricing and availability current as of June 2026

Novo Nordisk in August lowered the price of Ozempic for self-paying patients to $499 per month.

Currently, the scientific data on liraglutide dosing stems from clinical trials of Victoza and Saxenda, which have studied the peptide regarding its effects on conditions such as diabetes and obesity

During 2024 and 2025, the GLP-1 class was increasingly defined by expanded use cases and approvals, with existing drugs gaining indications including cardiovascular risk, sleep apnea and kidney disease